Hair Care Product Use among Women of Color

This clinical trial aims to further understand hair care product use and knowledge among women of color. Phthalates are a common ingredient in hair care products and is a well-known endocrine disrupting chemical. Endocrine disrupting chemicals from the surrounding environment may influence the risk of breast cancer; especially when women are exposed to endocrine disrupting chemicals while their breast tissue is changing (such as during pregnancy and postpartum). Learning about the different chemicals in hair care products may help participants make informed decisions about which hair care products they use.

Inclusion Criteria

• 18 years or older
• Within 0-4 weeks of the 3rd trimester of their pregnancy
• Speaks English and/or Spanish
• Lives within Northern Manhattan
• Black or Hispanic women

PRIMARY OBJECTIVE:

I. To reduce use of personal care products that contain endocrine disrupting chemicals among women.

OUTLINE:

Participants attend 1-2 group sessions via Zoom over 1.5-2.5 hours that includes information on the different chemicals found in hair care products. Participants also undergo collection of urine using a urine collection kit at home.

After completion of group sessions, participants are followed up by phone during mid-late third trimester and at 1-month postpartum.

Trial Phase Phase NA

Trial Type Prevention

Lead Organization
NYP / Columbia University Medical Center / Herbert Irving Comprehensive Cancer Center

Principal Investigator
Jasmine McDonald

• Primary ID AAAS9968
• Secondary IDs NCI-2020-11587
• Clinicaltrials.gov ID NCT04493892